tm logo
LIGEN
Live/Registered
REGISTERED

on 14 May 2024

Last Applicant/ Owned by

I-20122 MILANO

IT

Serial Number

79360498 filed on 23rd Nov 2022

Registration Number

7383355 registered on 14th May 2024

in the Principal Register

Correspondent Address

Theodore R. Remaklus

Theodore R. Remaklus Wood, Herron & Evans, L.L.P.

Suite 2800

Cincinnati, OH 45202

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

LIGEN

Software as a service (SAAS) services featuring software platforms using artificial intelligence for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; providing temp Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Software as a service (SAAS) services featuring software platforms using artificial intelligence for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; providing temporary use of online, non-downloadable artificial intelligence computer programs accessible via data networks for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; research in the field of artificial intelligence; design and development of computer software for operating medical technology in the nature of software for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; design and development of virtual screening software; design and development of virtual reality software for teaching medicine


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [009]
Computer & Software Products & Electrical & Scientific Products


Downloadable computer software for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; downloadable computer software for use by doctors and other medical professionals in capturing, tracking, reporting, analyzing health data in the field of medical decision support systems; downloadable virtual reality software for medical teaching, specifically, for granting user access to courses of instruction in the medical field; downloadable virtual screening software, specifically, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, and facilitates proof-of-concept testing in selected pre-clinical models; downloadable collaboration software platforms for use in database management in the field of medicine; downloadable computer software platforms for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; downloadable artificial intelligence software for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models in the field of healthcare


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79360498

Mark Type

No Service Mark

Attorney Docket Number

No BUGNION-252

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

26.19.01 -

Spheres

26.19.04 -

Cubes

Legal History


Show more

Status DateAction Taken
07th Nov 2024FINAL DISPOSITION PROCESSED
07th Nov 2024FINAL DISPOSITION NOTICE SENT TO IB
14th Aug 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14th May 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
14th May 2024REGISTERED-PRINCIPAL REGISTER
04th Mar 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27th Feb 2024PUBLISHED FOR OPPOSITION
26th Feb 2024NOTIFICATION PROCESSED BY IB
07th Feb 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07th Feb 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED